Cellectis S.A.
CLLS
$1.53
$0.021.33%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -21.51% | 100.97% | |||
| Total Other Revenue | 32.31% | 28.36% | |||
| Total Revenue | -15.99% | 89.95% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -15.99% | 89.95% | |||
| SG&A Expenses | -4.55% | 33.10% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 126.86% | 74.49% | |||
| Total Operating Expenses | -10.33% | 7.89% | |||
| Operating Income | 0.84% | 37.42% | |||
| Income Before Tax | 127.84% | 9.22% | |||
| Income Tax Expenses | 971.19% | 69.43% | |||
| Earnings from Continuing Operations | 125.69% | 8.76% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 125.69% | 8.76% | |||
| EBIT | 0.84% | 37.42% | |||
| EBITDA | 6.85% | 44.72% | |||
| EPS Basic | 125.71% | 18.10% | |||
| Normalized Basic EPS | 126.97% | 31.96% | |||
| EPS Diluted | 124.62% | 18.10% | |||
| Normalized Diluted EPS | 126.97% | 31.96% | |||
| Average Basic Shares Outstanding | 0.00% | 11.40% | |||
| Average Diluted Shares Outstanding | 0.00% | 11.40% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||